Core Scientific, Inc. Price & Performance (CORZW)

Core Scientific's stock surged by 10.88% following its Q4 2024 earnings report, despite a 33% revenue decline and widened net loss. The company reduced debt by $270 million and ended the year with over $830 million in cash. Analysts maintain strong buy ratings, citing future growth potential and restructuring success.12

Core Scientific is poised to benefit from CoreWeave’s upcoming IPO and its $12 billion OpenAI deal. Analysts suggest the IPO will solidify CoreWeave's stability, indirectly enhancing Core Scientific's revenue pipeline. The collaboration underscores Core Scientific's strategic role in high-performance computing for AI.34

Core Scientific reported mining 215 Bitcoins in February 2025, down from prior months, reflecting broader challenges in the cryptocurrency market. Despite operating 166,000 miners, revenue fell to $20.6 million for February. The company remains focused on diversifying its operations and adapting to market volatility.56